Novacyt to collaborate to validate HPV testing with NOVAprep® technology

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release

Visit Page

Novacyt launch next generation NOVAprep® instrumentation in China

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces an update to its launch of NOVAprep® in China through its partnership with Leica Biosystems. Download press release

Visit Page

Novacyt launches molecular HPV service to its NOVAPREP® customers

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics has launched a molecular HPV (Human Papillomavirus) service for all its customers who currently use its next generation NOVAprep® liquid-based cytology platform for cervical cancer screening. Download press release

Visit Page